Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Melanie, Hoppers"'
Publikováno v:
American Journal of Clinical Pathology. 157:602-607
Objectives The LumiraDx SARS-CoV-2 Ag Test has previously been shown to accurately detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals symptomatic for coronavirus disease 2019 (COVID-19). This evaluation investigated th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a73fc5a1089bd2449be16bc77289e8a0
https://doi.org/10.1093/ajcp/aqab173
https://doi.org/10.1093/ajcp/aqab173
Autor:
Andre B. Gvozden, Christopher Chappel, Melody Wang, Edward Zissman, Michalina A Montaño, Robert Rosen, Melanie Hoppers, Paul K. Drain, Madhavi Ampajwala, Stephen Young
Publikováno v:
Infectious Diseases and Therapy. 10:753-761
The LumiraDx severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen test, which uses a high-sensitivity, microfluidic immunoassay to detect the nucleocapsid protein of SARS-CoV-2, was evaluated for diagnosing acute coronavirus disease 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::291d360a489e888dcbf40e59c8ae9d34
https://doi.org/10.1007/s40121-021-00413-x
https://doi.org/10.1007/s40121-021-00413-x
Autor:
Joy Beeler, John H. Beigel, Justin Hoopes, H. Clifford Lane, Michael G. Ison, Christopher A Myers, Anchalee Avihingsanon, Kiat Ruxrungtham, Richard T. Davey, Weerawat Manosuthi, Michael Hughes, H Preston Holley, Marcelo H. Losso, Richard L Beasley, Nicholas Langlois, Melanie Hoppers, Yajing Bao
Publikováno v:
Clin Infect Dis
Background Duration of viral shedding is a determinant of infectivity and transmissibility, but few data exist about oseltamivir's ability to alter viral shedding. Methods From January 2012 through October 2017, a randomized, double-blinded multicent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e470354a06b11b49f76792289cc67b2a
https://doi.org/10.1093/cid/ciz634
https://doi.org/10.1093/cid/ciz634
Autor:
William, O'Riordan, Alison, McManus, Juri, Teras, Ivan, Poromanski, Maria, Cruz-Saldariagga, Megan, Quintas, Laura, Lawrence, ShuJui, Liang, Sue, Cammarata, Melanie, Hoppers
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
This phase 3 trial in acute bacterial skin and skin structure infections showed IV followed by oral delafloxacin to be noninferior to IV vancomycin/aztreonam combination therapy and well tolerated. Oral delafloxacin appears to maintain the initial re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7c933fdb65a60615741082043fe907f
https://pubmed.ncbi.nlm.nih.gov/30137243
https://pubmed.ncbi.nlm.nih.gov/30137243
Autor:
John H Beigel, Yajing Bao, Joy Beeler, Weerawat Manosuthi, Alex Slandzicki, Sadia M Dar, John Panuto, Richard L Beasley, Santiago Perez-Patrigeon, Gompol Suwanpimolkul, Marcelo H Losso, Natalie McClure, Dawn R Bozzolo, Christopher Myers, H Preston Holley, Justin Hoopes, H Clifford Lane, Michael D Hughes, Richard T Davey, Michael Winnie, Dinh V Dinh, Raghu Seethala, Hiram Garcia, Joe Pouzar, Michael Seep, Ernie Riffer, Belinda Bart, Sadia Dar, Melanie Hoppers, Heather Rowe, Cameron Wolfe, Donna Desantis, Barr Baynton, Norman Markowitz, Zebediah A Stearns, Josalyn Cho, Marcy Goisse, Thomas A Wolf, Jennifer Kay, Nila Dharan, William Fitzgibbons, Mark Woodruff, Todd Bell, Thomas Lenzmeier, Robert Schooley, Marie-Carmelle Elie, Patricia Winokur, Robert Finberg, Christopher Hurt, Pablo Tebas, Fred R Sattler, Madhavi Ampajwala, Donald Batts, Mark Bloch, Richard Moore, Dominic Dwyer, Javier Romo-Garcia, Santiago Perez Patrigeon, Ana Patricia Rodríguez Zulueta, Ploenchan Chetchotisakd, Kiat Ruxrungtham, Anchalee Avihingsanon, Winai Ratanasuwan, Sergio Lupo, Liliana Trape, Laura M Macias, Gustavo Lopardo, Laura Barcelona, Analia Mykietuk, Maria F Alzogaray
Publikováno v:
The Lancet. Infectious diseases
Summary Background Influenza continues to have a substantial socioeconomic and health impact despite a long established vaccination programme and approved antivirals. Preclinical data suggest that combining antivirals might be more effective than adm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::862b46a545f37ada255312740288945c
https://pubmed.ncbi.nlm.nih.gov/28958679
https://pubmed.ncbi.nlm.nih.gov/28958679
Autor:
Jason, Haffizulla, Aaron, Hartman, Melanie, Hoppers, Harvey, Resnick, Steve, Samudrala, Christine, Ginocchio, Matthew, Bardin, Jean-François, Rossignol, Gary, Yeoman
Publikováno v:
The Lancet. Infectious diseases. 14(7)
Summary Background Influenza is an important cause of morbidity and mortality worldwide. Treatment options are scarce, and new drugs with novel mechanisms of action are needed. We aimed to assess the efficacy and safety of nitazoxanide, a thiazolide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cc1b286233b2ea3e5435489a6047f64
https://pubmed.ncbi.nlm.nih.gov/24852377
https://pubmed.ncbi.nlm.nih.gov/24852377